Education
About Us
Working with TipRanks
Follow Us
IGC Pharma (IGC)
:IGC
IGC Pharma (IGC) Ownership Overview
1.04% Insiders
1.32% Mutual Funds
0.16% Other Institutional Investors
0.78% ETFs
97.74% Public Companies and
Individual Investors
The ownership structure of IGC Pharma (IGC) stock is a mix of institutional, retail, and individual investors. Approximately 2.26% of the company’s stock is owned by Institutional Investors, 1.04% is owned by Insiders, and 97.74% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Sep 27, 2024 | xxxxxxxxxxxxx | $200000 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 942,402 | Insider | 1.04% | 387,327 | |
| 718,436 | Institution | 0.78% | 286,656 | |
| 630,222 | Institution | 0.69% | 251,459 | |
| 586,649 | Institution | 0.64% | 234,073 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 630,222 | Institution | 0.69% | 251,459 | |
| 586,649 | Institution | 0.64% | 234,073 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 718,436 | Institution | 0.78% | 299,516 |
FAQ
Who Owns IGC Pharma (IGC)?
According to the latest TipRanks data, approximately 0.16% of the company's stock is held by institutional investors, 1.04% is held by insiders, and 97.74% is held by retail investors.
What percentage of IGC Pharma (IGC) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.16% of IGC Pharma (IGC) stock is held by institutional investors.
What percentage of IGC Pharma (IGC) stock is held by retail investors?
According to the latest TipRanks data, approximately 97.74% of IGC Pharma (IGC) stock is held by retail investors.
Who owns the most shares of IGC Pharma (IGC)?
James P Moran owns the most shares of IGC Pharma (IGC).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.